Irregular poliovirus vaccination correlates to pulmonary edema of hand, foot, and mouth disease.
作者信息
Deng Chaoyang, Yang Chunfu, Wan Junfeng, Zhu Liye, Leng Qibin
出版信息
Clin Vaccine Immunol. 2011 Sep;18(9):1589-90. doi: 10.1128/CVI.05132-11. Epub 2011 Jul 13.
Abstract
摘要
相似文献
1
Irregular poliovirus vaccination correlates to pulmonary edema of hand, foot, and mouth disease.不规范的脊髓灰质炎疫苗接种与手足口病的肺水肿相关。
Clin Vaccine Immunol. 2011 Sep;18(9):1589-90. doi: 10.1128/CVI.05132-11. Epub 2011 Jul 13.
2
Poliovirus vaccination.
Lancet. 1993 Aug 7;342(8867):370-1.
3
Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).美国的脊髓灰质炎预防：采用先接种灭活脊髓灰质炎病毒疫苗后接种口服脊髓灰质炎病毒疫苗的序贯接种程序。免疫实践咨询委员会（ACIP）的建议
MMWR Recomm Rep. 1997 Jan 24;46(RR-3):1-25.
4
[Observation on safety of sequential vaccination schedule of different strain inactivated poliovirus vaccines].不同株脊髓灰质炎灭活疫苗序贯接种程序安全性观察
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 May 10;40(5):565-570. doi: 10.3760/cma.j.issn.0254-6450.2019.05.014.
5
New recommendations for poliovirus vaccination. Combination regimen captures best effects of available vaccines.脊髓灰质炎病毒疫苗接种新建议。联合方案可发挥现有疫苗的最佳效果。
Postgrad Med. 1997 Nov;102(5):45-8, 51-3, 59-60 passim. doi: 10.3810/pgm.1997.11.366.
6
Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial.通过比较中国不同脊髓灰质炎疫苗接种程序评估1型和3型口服脊髓灰质炎二价疫苗的免疫原性和安全性：一项随机对照非劣效性临床试验
Hum Vaccin Immunother. 2017 Jun 3;13(6):1-10. doi: 10.1080/21645515.2017.1288769. Epub 2017 Mar 1.
7
Neutralising antibody response to oral poliovirus vaccine after primary immunisation with inactivated poliovirus vaccine.用灭活脊髓灰质炎病毒疫苗进行初次免疫后对口服脊髓灰质炎病毒疫苗的中和抗体反应。
Eur J Clin Microbiol Infect Dis. 1998 Nov;17(11):815-6. doi: 10.1007/s100960050198.
8
Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.脊髓灰质炎病毒免疫获得的监测，包括用萨宾株来源的灭活疫苗进行免疫接种。
Hum Vaccin Immunother. 2019;15(5):1154-1159. doi: 10.1080/21645515.2019.1572408. Epub 2019 Mar 11.
9
10
[Preventive poliomyelitis immunization].
Z Arztl Fortbild (Jena). 1990;84(8):365-7.
引用本文的文献
1
Severe enterovirus A71 infection is associated with dysfunction of T cell immune response and alleviated by Astragaloside A.严重肠道病毒A71感染与T细胞免疫反应功能障碍相关，且被黄芪甲苷减轻。
Virol Sin. 2025 Jun;40(3):451-461. doi: 10.1016/j.virs.2025.05.010. Epub 2025 May 29.
2
Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.中国的手足口病：肠道病毒血清型流行动态建模及疫苗接种的意义
PLoS Med. 2016 Feb 16;13(2):e1001958. doi: 10.1371/journal.pmed.1001958. eCollection 2016 Feb.
3
The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.人用和兽用肠道病毒71型灭活疫苗与柯萨奇病毒A16型和脊髓灰质炎病毒疫苗的兼容性。
Hum Vaccin Immunother. 2015;11(11):2723-33. doi: 10.1080/21645515.2015.1011975. Epub 2015 Feb 25.
4
TLR3 signaling in macrophages is indispensable for the protective immunity of invariant natural killer T cells against enterovirus 71 infection.巨噬细胞中的Toll样受体3（TLR3）信号传导对于恒定自然杀伤T细胞针对肠道病毒71型感染的保护性免疫至关重要。
PLoS Pathog. 2015 Jan 23;11(1):e1004613. doi: 10.1371/journal.ppat.1004613. eCollection 2015 Jan.
5
A dominant EV71-specific CD4+ T cell epitope is highly conserved among human enteroviruses.一种优势 EV71 特异性 CD4+ T 细胞表位在人类肠道病毒中高度保守。
PLoS One. 2012;7(12):e51957. doi: 10.1371/journal.pone.0051957. Epub 2012 Dec 14.
本文引用的文献
1
Japanese bilateral cooperation for the promotion of poliomyelitis eradication in China.日本促进中国消灭脊髓灰质炎的双边合作。
Vaccine. 2010 Aug 31;28(38):6398-402. doi: 10.1016/j.vaccine.2010.05.009. Epub 2010 May 16.
2
Immunization status and risk factors of migrant children in densely populated areas of Beijing, China.中国北京人口密集地区流动儿童的免疫状况及危险因素。
Vaccine. 2010 Feb 3;28(5):1264-74. doi: 10.1016/j.vaccine.2009.11.015. Epub 2009 Nov 24.
3
An overview of the evolution of enterovirus 71 and its clinical and public health significance.肠道病毒71型的进化及其临床和公共卫生意义概述。
FEMS Microbiol Rev. 2002 Mar;26(1):91-107. doi: 10.1111/j.1574-6976.2002.tb00601.x.
4
The final stages of the global eradication of polio.全球消灭脊髓灰质炎的最后阶段。
N Engl J Med. 2000 Sep 14;343(11):806-7. doi: 10.1056/NEJM200009143431111.
5
An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.台湾肠道病毒71型感染疫情。台湾肠道病毒疫情工作小组。
N Engl J Med. 1999 Sep 23;341(13):929-35. doi: 10.1056/NEJM199909233411301.
6
A study of the cellular immune response to enteroviruses in humans: identification of cross-reactive T cell epitopes on the structural proteins of enteroviruses.一项关于人类对肠道病毒细胞免疫反应的研究：肠道病毒结构蛋白上交叉反应性T细胞表位的鉴定
J Gen Virol. 1996 Sep;77 ( Pt 9):2097-108. doi: 10.1099/0022-1317-77-9-2097.
7
Molecular basis for serological cross-reactivity between enteroviruses.肠道病毒之间血清学交叉反应性的分子基础。
Clin Diagn Lab Immunol. 1994 May;1(3):336-41. doi: 10.1128/cdli.1.3.336-341.1994.
8
Enterovirus survey before and after poliomyelitis vaccination in Kuala Lumpur, Malaysia.马来西亚吉隆坡脊髓灰质炎疫苗接种前后肠道病毒调查
Southeast Asian J Trop Med Public Health. 1978 Sep;9(3):301-7.
Zotero 插件